Mette-Marit Lung Transplant: Crown Princess Discharged and Enters Six-Month Rehabilitation
Crown Princess Mette-Marit discharged after lung transplant; will undergo six months of rehabilitation with close medical monitoring and no official duties.
Norway’s Crown Princess Mette-Marit was discharged from hospital on July 14, 2026, four weeks after undergoing a lung transplant, the royal household announced. The Mette-Marit lung transplant marks a major step in her recovery from pulmonary fibrosis, and palace doctors said her condition is progressing as expected. The Crown Princess will now begin a structured rehabilitation programme and will not undertake official duties while under close medical supervision.
Royal Household Confirms Discharge
The Royal Court issued a statement confirming that the Crown Princess, aged 52, left hospital on July 14, 2026, following post-operative recovery. Officials described her health as “good” given the circumstances and said medical teams will continue to assess her progress. The statement emphasized that all follow-up care will be coordinated by specialists in transplantation and rehabilitation medicine.
Planned Six-Month Rehabilitation
Doctors have outlined a six-month rehabilitation plan to support the Crown Princess’s recovery and to monitor for possible complications. The programme will include respiratory therapy, physical conditioning, and regular clinic visits to check organ function and overall fitness. Rehabilitation teams will aim to balance gradual increases in activity with careful surveillance for signs of organ rejection or infection.
Details of the June 2026 Transplant
Mette-Marit was diagnosed with treatment-resistant pulmonary fibrosis in 2018 and was placed on the transplant waiting list earlier this year. She received a donor lung in June 2026 after a short period on the list, according to the palace announcement. The operation and immediate post-operative care were carried out by a specialised transplant team, and the four-week hospital stay allowed clinicians to stabilise her condition before discharge.
Medical Risks and Monitoring
Physicians warned that vigilance is essential during the months following the transplant because risks such as organ rejection and infectious complications remain elevated. The Crown Princess will undergo frequent blood tests, imaging studies and pulmonary function assessments to detect early signs of complications. Immunosuppressive therapy will be adjusted as needed to reduce rejection risk while minimising side effects.
Impact on Official Duties and Royal Schedule
The Royal Court made clear that Mette-Marit will not perform public duties during the rehabilitation period, delegating official engagements as necessary. Crown Prince Haakon, her husband, expressed relief at the improvement in her condition and is expected to support her recovery while fulfilling his constitutional and representative roles. The palace indicated that scheduled events involving the Crown Princess will be postponed or handled by other members of the royal family.
Public Reaction and Next Steps
Public response in Norway has been one of concern and solidarity, with many citizens and institutions sending well-wishes to the Crown Princess and her family. The palace said it will provide periodic updates on her recovery while respecting medical confidentiality and the family’s privacy. Officials also noted that any significant developments, whether improvements or setbacks, will be communicated promptly.
The successful transplant and hospital discharge mark a hopeful phase in Mette-Marit’s longer recovery journey, but clinicians stress that full recuperation will take time and careful management. The coming months will focus on rehabilitation, monitoring and incremental resumption of normal activities according to medical advice.
The palace has asked the public and media to respect the family’s need for privacy while allowing medical teams to concentrate on the Crown Princess’s care.
